tiprankstipranks
Trending News
More News >
Y-Mabs Therapeutics (YMAB)
NASDAQ:YMAB
US Market
Advertisement

Y-Mabs Therapeutics (YMAB) Similar Stocks

Compare
516 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Y-Mabs Therapeutics
$4.77
$219.23M
-61.93%
6 Buy
0 Hold
2 Sell
Moderate Buy
Omeros
$3.83
$210.35M
-26.63%
1 Buy
1 Hold
0 Sell
Moderate Buy
Genfit SA
$4.14
$207.20M
120.27
3.24%
0 Buy
0 Hold
0 Sell
Hold
RAPT Therapeutics
$12.65
$209.18M
-50.19%
4 Buy
1 Hold
1 Sell
Moderate Buy
4D Molecular Therapeutics
$4.61
$213.56M
-75.10%
5 Buy
1 Hold
1 Sell
Moderate Buy
Caribou Biosciences
$2.37
$220.42M
-8.43%
4 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
YMAB
Y-Mabs Therapeutics
4.77
-7.76
-61.93%
OMER
Omeros
3.83
-1.39
-26.63%
GNFT
Genfit SA
4.14
0.13
3.24%
RAPT
RAPT Therapeutics
13.31
-13.41
-50.19%
FDMT
4D Molecular Therapeutics
4.57
-13.78
-75.10%
CRBU
Caribou Biosciences
2.28
-0.21
-8.43%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis